<![CDATA[<body bgcolor="#FFFFFF">
The Angiogenesis Foundation is a 501(c)(3) nonprofit organization based in Cambridge, Massachusetts, USA. Founded in 1994, the Foundation was created by Harvard-trained physicians, scientists, and humanitarians who share a vision that healthcare in the 21st century will be revolutionized by medicines that control angiogenesis.
<p>Angiogenesis (new blood vessel growth) is the "common denominator" in
society's most significant diseases, including cancer, heart disease,
stroke, blindness, arthritis, psoriasis, complications of AIDS, and more
than 70 other conditions.
<p>By combining the effective use of knowledge, research, and education, the Angiogenesis Foundation takes a comprehensive and integrative approach towards helping society create and benefit from angiogenesis-based medicines. Since its inception, the Foundation has worked collaboratively with leaders in government, industry, universities, medicine, and patients and their support groups.
<p>The Angiogenesis Foundation serves as:
<ol type="1">
<p><li>A global information clearinghouse
<p><li>A research and education institute
<p><li>A think tank for new drug development and therapy adoption
</ol>
<p><a class="nu" href="content_foundation.html">About the Foundation</a>
</body>]]>